ArticleFrontiers in medicine2021

Non-immune Prophylaxis Against COVID-19 by Targeting Tolerance for Angiotensin II-Triggered SARS-CoV-2 Pathogenesis.

Michael V DubinaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.